NCT04884386

Brief Summary

In children with cerebral palsy, the quality of walking decreases due to a decrease in the ability to control limbs, including walking, and coordination among various activities of daily living due to a decrease in functional independence and quality of life. Gait disorder is one of the important therapeutic goals of children with cerebral palsy, and recently robot-assisted gait training (RAGT) induces changes in brain plasticity, so it will help improve gross motor control and coordination control.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
22

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 8, 2021

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 13, 2021

Completed
1 month until next milestone

Study Start

First participant enrolled

June 12, 2021

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 30, 2021

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2021

Completed
Last Updated

November 22, 2021

Status Verified

November 1, 2021

Enrollment Period

3 months

First QC Date

May 8, 2021

Last Update Submit

November 18, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • muscle activation

    Measure muscle activity of Sternocleidomastoid, C4 Cervical Paraspinals, L5 Paraspinals, Rectus Femoris, Medial Hamstring, and Soleus during functional reach test. Surface electromyograph(EMG)(Mini Wave Infinity Waterproof, Cometa Systems, Italy, 2017) was used to measure muscle activity, and analysis software(Myoresearch XP Master 1.07, Noraxon, USA, 2011) was used for EMG analysis. The sampling rate was set to 2000 Hz. The EMG raw data was quantified as 150 ms after applying full wave rectification, and filtering was performed in the range of 20 to 450 Hz using a digital band-pass filter (Lancosh FIR). do

    Change from baseline muscle activation at 4 weeks

Study Arms (2)

robot-assisted gait training

EXPERIMENTAL
Device: robot-assisted gait trainingBehavioral: conventional locomotion therapy

conventional locomotion therapy

ACTIVE COMPARATOR
Behavioral: conventional locomotion therapy

Interventions

RAGT, WALKBOT-G, is a walking training equipment that can reproduce natural motions by adjusting the leg length and adjusting the motion with the actuator of the ankle joint.

robot-assisted gait training

locomotion exercise, postural control training, balance training, electrotherapy

conventional locomotion therapyrobot-assisted gait training

Eligibility Criteria

Age6 Years - 12 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Patients aged 6-12 years or younger who have not received botulinum toxin or surgery within 3 months before the study
  • Patients diagnosed with Bilateral Spastic Cerebral Palsy
  • Patients diagnosed with Spastic Hemiplegic Cerebral Palsy

You may not qualify if:

  • Children who cannot understand and follow orders
  • Children with stiffness in the lower limbs corresponding to the Modified Ashworth Scale (MAS)\> 3
  • Patients who wear a robot and walk without affecting contractures, deformities, or skin problems
  • Infants with cardiovascular instability and mild scoliosis with a cobb's angle of 30 degrees or more

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ez rehabilitation medical center

Yongin-si, 16943, South Korea

Location

MeSH Terms

Conditions

Cerebral PalsyGait Disorders, Neurologic

Condition Hierarchy (Ancestors)

Brain Damage, ChronicBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
collaborator

Study Record Dates

First Submitted

May 8, 2021

First Posted

May 13, 2021

Study Start

June 12, 2021

Primary Completion

August 30, 2021

Study Completion

September 30, 2021

Last Updated

November 22, 2021

Record last verified: 2021-11

Locations